TrialVaccine2012

Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.

Wilbur H Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.